LncRNA-MALAT1: A Key Participant in the Occurrence and Development of Cancer

LncRNAs are a group of non-coding RNA transcripts with lengths of over 200 nucleotides and can interact with DNA, RNA, and proteins to regulate gene expression of malignant tumors in human tissues. LncRNAs participate in vital processes, such as chromosomal nuclear transport in the cancerous site of...

Full description

Saved in:
Bibliographic Details
Published in:Molecules (Basel, Switzerland) Switzerland), 2023-02, Vol.28 (5), p.2126
Main Authors: Hao, Longhui, Wu, Wenzheng, Xu, Yankun, Chen, Yufan, Meng, Chengzhen, Yun, Jingyi, Wang, Xiaoyu
Format: Article
Language:English
Subjects:
action pathway
Apoptosis
Cancer
Cell differentiation
Cell growth
Cell Line, Tumor
Chromosomes
Cytoplasm
Development and progression
DNA methylation
Drug development
Epigenetics
Gene expression
Genes
Genomes
Health aspects
Homeostasis
Human tissues
Humans
Immune system
lncRNA-MALAT1
long non-coding RNA
Lung cancer
mechanism
Metastases
Metastasis
MicroRNAs
Neoplasms - pathology
Non-coding RNA
Nuclear transport
Nucleotides
Pancreatic cancer
Physiology
Proteins
Proto-oncogenes
Review
RNA
RNA, Long Noncoding - genetics
Signal transduction
Therapeutic targets
Transcription factors
Tumors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c561t-cd7122bb761c34388328e274e4e758bbff42c3d51f914a8605b66eb1eaebcf153
cites cdi_FETCH-LOGICAL-c561t-cd7122bb761c34388328e274e4e758bbff42c3d51f914a8605b66eb1eaebcf153
container_end_page
container_issue 5
container_start_page 2126
container_title Molecules (Basel, Switzerland)
container_volume 28
creator Hao, Longhui
Wu, Wenzheng
Xu, Yankun
Chen, Yufan
Meng, Chengzhen
Yun, Jingyi
Wang, Xiaoyu
description LncRNAs are a group of non-coding RNA transcripts with lengths of over 200 nucleotides and can interact with DNA, RNA, and proteins to regulate gene expression of malignant tumors in human tissues. LncRNAs participate in vital processes, such as chromosomal nuclear transport in the cancerous site of human tissue, activation, and the regulation of proto-oncogenes, the differentiation of immune cells, and the regulation of the cellular immune system. The lncRNA metastasis-associated lung cancer transcript 1 (MALAT1) is reportedly involved in the occurrence and development of many cancers and serves as a biomarker and therapeutic target. These findings highlight its promising role in cancer treatment. In this article, we comprehensively summarized the structure and functions of lncRNA, notably the discoveries of lncRNA-MALAT1 in different cancers, the action mechanisms, and the ongoing research on new drug development. We believe our review would serve as a basis for further research on the pathological mechanism of lncRNA-MALAT1 in cancer and provide evidence and novel insights into its application in clinical diagnoses and treatments.
doi_str_mv 10.3390/molecules28052126
format article
fullrecord <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_0e6f1b926d7a4eaabc4af3adab8959e8</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A741845262</galeid><doaj_id>oai_doaj_org_article_0e6f1b926d7a4eaabc4af3adab8959e8</doaj_id><sourcerecordid>A741845262</sourcerecordid><originalsourceid>FETCH-LOGICAL-c561t-cd7122bb761c34388328e274e4e758bbff42c3d51f914a8605b66eb1eaebcf153</originalsourceid><addsrcrecordid>eNptUk1v1DAQjRCIlsIP4IIiceGS4u84XFC0fFUEilA5W7Yz3nqV2IuTVOq_x9stpQvIkj2aee-N3niK4jlGp5Q26PUYB7DLABORiBNMxIPiGDOCKopY8_BefFQ8maYNQgQzzB8XR1Q0iObruOi6YL9_basvbdde4DdlW36G6_KbTrO3fqvDXPpQzpdQnlu7pATBQqlDX76DKxjidoSMiK5c6VxIT4tHTg8TPLt9T4ofH95frD5V3fnHs1XbVZYLPFe2rzEhxtQCW8qolJRIIDUDBjWXxjjHiKU9x67BTEuBuBECDAYNxjrM6Ulxttfto96obfKjTtcqaq9uEjGt1Y2BARQC4bBpiOhrzUBrY5l2VPfayIY3ILPW273WdjEj9DYbSno4ED2sBH-p1vFKYYQQ4xJnhVe3Cin-XGCa1egnC8OgA8RlUqTOFhrOxa7Zy7-gm7ikkGe1Q-UvrJua_kGtdXbgg4u5sd2JqrZmWDJOBMmo0_-g8ulh9DYGcD7nDwh4T7ApTlMCd2cSI7XbJ_XPPmXOi_vTuWP8XiD6Czk0xbQ</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2785217973</pqid></control><display><type>article</type><title>LncRNA-MALAT1: A Key Participant in the Occurrence and Development of Cancer</title><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Hao, Longhui ; Wu, Wenzheng ; Xu, Yankun ; Chen, Yufan ; Meng, Chengzhen ; Yun, Jingyi ; Wang, Xiaoyu</creator><creatorcontrib>Hao, Longhui ; Wu, Wenzheng ; Xu, Yankun ; Chen, Yufan ; Meng, Chengzhen ; Yun, Jingyi ; Wang, Xiaoyu</creatorcontrib><description>LncRNAs are a group of non-coding RNA transcripts with lengths of over 200 nucleotides and can interact with DNA, RNA, and proteins to regulate gene expression of malignant tumors in human tissues. LncRNAs participate in vital processes, such as chromosomal nuclear transport in the cancerous site of human tissue, activation, and the regulation of proto-oncogenes, the differentiation of immune cells, and the regulation of the cellular immune system. The lncRNA metastasis-associated lung cancer transcript 1 (MALAT1) is reportedly involved in the occurrence and development of many cancers and serves as a biomarker and therapeutic target. These findings highlight its promising role in cancer treatment. In this article, we comprehensively summarized the structure and functions of lncRNA, notably the discoveries of lncRNA-MALAT1 in different cancers, the action mechanisms, and the ongoing research on new drug development. We believe our review would serve as a basis for further research on the pathological mechanism of lncRNA-MALAT1 in cancer and provide evidence and novel insights into its application in clinical diagnoses and treatments.</description><identifier>ISSN: 1420-3049</identifier><identifier>EISSN: 1420-3049</identifier><identifier>DOI: 10.3390/molecules28052126</identifier><identifier>PMID: 36903369</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>action pathway ; Apoptosis ; Cancer ; Cell differentiation ; Cell growth ; Cell Line, Tumor ; Chromosomes ; Cytoplasm ; Development and progression ; DNA methylation ; Drug development ; Epigenetics ; Gene expression ; Genes ; Genomes ; Health aspects ; Homeostasis ; Human tissues ; Humans ; Immune system ; lncRNA-MALAT1 ; long non-coding RNA ; Lung cancer ; mechanism ; Metastases ; Metastasis ; MicroRNAs ; Neoplasms - pathology ; Non-coding RNA ; Nuclear transport ; Nucleotides ; Pancreatic cancer ; Physiology ; Proteins ; Proto-oncogenes ; Review ; RNA ; RNA, Long Noncoding - genetics ; Signal transduction ; Therapeutic targets ; Transcription factors ; Tumors</subject><ispartof>Molecules (Basel, Switzerland), 2023-02, Vol.28 (5), p.2126</ispartof><rights>COPYRIGHT 2023 MDPI AG</rights><rights>2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2023 by the authors. 2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c561t-cd7122bb761c34388328e274e4e758bbff42c3d51f914a8605b66eb1eaebcf153</citedby><cites>FETCH-LOGICAL-c561t-cd7122bb761c34388328e274e4e758bbff42c3d51f914a8605b66eb1eaebcf153</cites><orcidid>0000-0003-0578-7650 ; 0000-0002-9708-4081</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2785217973/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2785217973?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,25731,27901,27902,36989,36990,44566,53766,53768,74869</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36903369$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hao, Longhui</creatorcontrib><creatorcontrib>Wu, Wenzheng</creatorcontrib><creatorcontrib>Xu, Yankun</creatorcontrib><creatorcontrib>Chen, Yufan</creatorcontrib><creatorcontrib>Meng, Chengzhen</creatorcontrib><creatorcontrib>Yun, Jingyi</creatorcontrib><creatorcontrib>Wang, Xiaoyu</creatorcontrib><title>LncRNA-MALAT1: A Key Participant in the Occurrence and Development of Cancer</title><title>Molecules (Basel, Switzerland)</title><addtitle>Molecules</addtitle><description>LncRNAs are a group of non-coding RNA transcripts with lengths of over 200 nucleotides and can interact with DNA, RNA, and proteins to regulate gene expression of malignant tumors in human tissues. LncRNAs participate in vital processes, such as chromosomal nuclear transport in the cancerous site of human tissue, activation, and the regulation of proto-oncogenes, the differentiation of immune cells, and the regulation of the cellular immune system. The lncRNA metastasis-associated lung cancer transcript 1 (MALAT1) is reportedly involved in the occurrence and development of many cancers and serves as a biomarker and therapeutic target. These findings highlight its promising role in cancer treatment. In this article, we comprehensively summarized the structure and functions of lncRNA, notably the discoveries of lncRNA-MALAT1 in different cancers, the action mechanisms, and the ongoing research on new drug development. We believe our review would serve as a basis for further research on the pathological mechanism of lncRNA-MALAT1 in cancer and provide evidence and novel insights into its application in clinical diagnoses and treatments.</description><subject>action pathway</subject><subject>Apoptosis</subject><subject>Cancer</subject><subject>Cell differentiation</subject><subject>Cell growth</subject><subject>Cell Line, Tumor</subject><subject>Chromosomes</subject><subject>Cytoplasm</subject><subject>Development and progression</subject><subject>DNA methylation</subject><subject>Drug development</subject><subject>Epigenetics</subject><subject>Gene expression</subject><subject>Genes</subject><subject>Genomes</subject><subject>Health aspects</subject><subject>Homeostasis</subject><subject>Human tissues</subject><subject>Humans</subject><subject>Immune system</subject><subject>lncRNA-MALAT1</subject><subject>long non-coding RNA</subject><subject>Lung cancer</subject><subject>mechanism</subject><subject>Metastases</subject><subject>Metastasis</subject><subject>MicroRNAs</subject><subject>Neoplasms - pathology</subject><subject>Non-coding RNA</subject><subject>Nuclear transport</subject><subject>Nucleotides</subject><subject>Pancreatic cancer</subject><subject>Physiology</subject><subject>Proteins</subject><subject>Proto-oncogenes</subject><subject>Review</subject><subject>RNA</subject><subject>RNA, Long Noncoding - genetics</subject><subject>Signal transduction</subject><subject>Therapeutic targets</subject><subject>Transcription factors</subject><subject>Tumors</subject><issn>1420-3049</issn><issn>1420-3049</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNptUk1v1DAQjRCIlsIP4IIiceGS4u84XFC0fFUEilA5W7Yz3nqV2IuTVOq_x9stpQvIkj2aee-N3niK4jlGp5Q26PUYB7DLABORiBNMxIPiGDOCKopY8_BefFQ8maYNQgQzzB8XR1Q0iObruOi6YL9_basvbdde4DdlW36G6_KbTrO3fqvDXPpQzpdQnlu7pATBQqlDX76DKxjidoSMiK5c6VxIT4tHTg8TPLt9T4ofH95frD5V3fnHs1XbVZYLPFe2rzEhxtQCW8qolJRIIDUDBjWXxjjHiKU9x67BTEuBuBECDAYNxjrM6Ulxttfto96obfKjTtcqaq9uEjGt1Y2BARQC4bBpiOhrzUBrY5l2VPfayIY3ILPW273WdjEj9DYbSno4ED2sBH-p1vFKYYQQ4xJnhVe3Cin-XGCa1egnC8OgA8RlUqTOFhrOxa7Zy7-gm7ikkGe1Q-UvrJua_kGtdXbgg4u5sd2JqrZmWDJOBMmo0_-g8ulh9DYGcD7nDwh4T7ApTlMCd2cSI7XbJ_XPPmXOi_vTuWP8XiD6Czk0xbQ</recordid><startdate>20230224</startdate><enddate>20230224</enddate><creator>Hao, Longhui</creator><creator>Wu, Wenzheng</creator><creator>Xu, Yankun</creator><creator>Chen, Yufan</creator><creator>Meng, Chengzhen</creator><creator>Yun, Jingyi</creator><creator>Wang, Xiaoyu</creator><general>MDPI AG</general><general>MDPI</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0003-0578-7650</orcidid><orcidid>https://orcid.org/0000-0002-9708-4081</orcidid></search><sort><creationdate>20230224</creationdate><title>LncRNA-MALAT1: A Key Participant in the Occurrence and Development of Cancer</title><author>Hao, Longhui ; Wu, Wenzheng ; Xu, Yankun ; Chen, Yufan ; Meng, Chengzhen ; Yun, Jingyi ; Wang, Xiaoyu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c561t-cd7122bb761c34388328e274e4e758bbff42c3d51f914a8605b66eb1eaebcf153</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>action pathway</topic><topic>Apoptosis</topic><topic>Cancer</topic><topic>Cell differentiation</topic><topic>Cell growth</topic><topic>Cell Line, Tumor</topic><topic>Chromosomes</topic><topic>Cytoplasm</topic><topic>Development and progression</topic><topic>DNA methylation</topic><topic>Drug development</topic><topic>Epigenetics</topic><topic>Gene expression</topic><topic>Genes</topic><topic>Genomes</topic><topic>Health aspects</topic><topic>Homeostasis</topic><topic>Human tissues</topic><topic>Humans</topic><topic>Immune system</topic><topic>lncRNA-MALAT1</topic><topic>long non-coding RNA</topic><topic>Lung cancer</topic><topic>mechanism</topic><topic>Metastases</topic><topic>Metastasis</topic><topic>MicroRNAs</topic><topic>Neoplasms - pathology</topic><topic>Non-coding RNA</topic><topic>Nuclear transport</topic><topic>Nucleotides</topic><topic>Pancreatic cancer</topic><topic>Physiology</topic><topic>Proteins</topic><topic>Proto-oncogenes</topic><topic>Review</topic><topic>RNA</topic><topic>RNA, Long Noncoding - genetics</topic><topic>Signal transduction</topic><topic>Therapeutic targets</topic><topic>Transcription factors</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hao, Longhui</creatorcontrib><creatorcontrib>Wu, Wenzheng</creatorcontrib><creatorcontrib>Xu, Yankun</creatorcontrib><creatorcontrib>Chen, Yufan</creatorcontrib><creatorcontrib>Meng, Chengzhen</creatorcontrib><creatorcontrib>Yun, Jingyi</creatorcontrib><creatorcontrib>Wang, Xiaoyu</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Molecules (Basel, Switzerland)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hao, Longhui</au><au>Wu, Wenzheng</au><au>Xu, Yankun</au><au>Chen, Yufan</au><au>Meng, Chengzhen</au><au>Yun, Jingyi</au><au>Wang, Xiaoyu</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>LncRNA-MALAT1: A Key Participant in the Occurrence and Development of Cancer</atitle><jtitle>Molecules (Basel, Switzerland)</jtitle><addtitle>Molecules</addtitle><date>2023-02-24</date><risdate>2023</risdate><volume>28</volume><issue>5</issue><spage>2126</spage><pages>2126-</pages><issn>1420-3049</issn><eissn>1420-3049</eissn><abstract>LncRNAs are a group of non-coding RNA transcripts with lengths of over 200 nucleotides and can interact with DNA, RNA, and proteins to regulate gene expression of malignant tumors in human tissues. LncRNAs participate in vital processes, such as chromosomal nuclear transport in the cancerous site of human tissue, activation, and the regulation of proto-oncogenes, the differentiation of immune cells, and the regulation of the cellular immune system. The lncRNA metastasis-associated lung cancer transcript 1 (MALAT1) is reportedly involved in the occurrence and development of many cancers and serves as a biomarker and therapeutic target. These findings highlight its promising role in cancer treatment. In this article, we comprehensively summarized the structure and functions of lncRNA, notably the discoveries of lncRNA-MALAT1 in different cancers, the action mechanisms, and the ongoing research on new drug development. We believe our review would serve as a basis for further research on the pathological mechanism of lncRNA-MALAT1 in cancer and provide evidence and novel insights into its application in clinical diagnoses and treatments.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>36903369</pmid><doi>10.3390/molecules28052126</doi><orcidid>https://orcid.org/0000-0003-0578-7650</orcidid><orcidid>https://orcid.org/0000-0002-9708-4081</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1420-3049
ispartof Molecules (Basel, Switzerland), 2023-02, Vol.28 (5), p.2126
issn 1420-3049
1420-3049
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_0e6f1b926d7a4eaabc4af3adab8959e8
source Publicly Available Content Database; PubMed Central
subjects action pathway
Apoptosis
Cancer
Cell differentiation
Cell growth
Cell Line, Tumor
Chromosomes
Cytoplasm
Development and progression
DNA methylation
Drug development
Epigenetics
Gene expression
Genes
Genomes
Health aspects
Homeostasis
Human tissues
Humans
Immune system
lncRNA-MALAT1
long non-coding RNA
Lung cancer
mechanism
Metastases
Metastasis
MicroRNAs
Neoplasms - pathology
Non-coding RNA
Nuclear transport
Nucleotides
Pancreatic cancer
Physiology
Proteins
Proto-oncogenes
Review
RNA
RNA, Long Noncoding - genetics
Signal transduction
Therapeutic targets
Transcription factors
Tumors
title LncRNA-MALAT1: A Key Participant in the Occurrence and Development of Cancer
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T06%3A59%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=LncRNA-MALAT1:%20A%20Key%20Participant%20in%20the%20Occurrence%20and%20Development%20of%20Cancer&rft.jtitle=Molecules%20(Basel,%20Switzerland)&rft.au=Hao,%20Longhui&rft.date=2023-02-24&rft.volume=28&rft.issue=5&rft.spage=2126&rft.pages=2126-&rft.issn=1420-3049&rft.eissn=1420-3049&rft_id=info:doi/10.3390/molecules28052126&rft_dat=%3Cgale_doaj_%3EA741845262%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c561t-cd7122bb761c34388328e274e4e758bbff42c3d51f914a8605b66eb1eaebcf153%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2785217973&rft_id=info:pmid/36903369&rft_galeid=A741845262&rfr_iscdi=true